n-{[5-(2-chloroacetyl)thiophen-2-yl]methyl}acetamide, 97%, 100mg

(4S,4'S)-4,4'-Dicyclohexyl-1,1'-bis(2,6-dimethylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

1-(Tetrahydro-2H-pyran-4-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

6-AMINO-1,1-DIOXO-1,2-BENZOTHIAZOL-3-ONE, 95.0%, 250mg

(3S,4R)-1-(tert-Butoxycarbonyl)-3-fluoropiperidine-4-carboxylic acid, 97%, 1g

N-Benzyl-2,2,2-trifluoroacetamide>95.0%(GC)5g

(2-Aminopyridin-4-yl)dimethylphosphine oxide, 98%, 1g

Anthraquinone-2-carbonyl Chloride>98.0%(HPLC)(T)25g

2,4-dimethyl-2'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

Single-channel microliter pipette Eppendorf Research® plus, 250 to 2500 µl, red, 1 piece

N-(Piperidin-4-yl)benzenesulfonamide, 95.0%, 1g

4-Allylanisole>98.0%(GC)100g

5-Bromo-4-chloro-1H-pyrazole, 95+%, 25g